Investigational new drug application (IND)

In Regulatory & approvals

An IND is the application a sponsor files with the FDA to begin testing a new drug in people in the United States. It contains the manufacturing information, the animal and laboratory data, the protocol, and investigator details. The trial may generally begin after 30 days unless the FDA places it on clinical hold.

Turn the vocabulary into a career

The free CRLN Career Finder maps your background to a clinical-research role and builds a step-by-step roadmap. No cost, no card.

Educational reference only. Where regional rules differ, follow the regulation and the written procedures that apply where you work.